Processa Pharmaceuticals, Inc.

PCSA

$2.05

-2.38%

N/A-$0.05

Healthcare

Biotechnology

NASDAQ

Active Trading

Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with ...

C-Suite Executives

(0)

The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.

Key Team Members

No executives available for this level

Founder / CEO

C-Level

Board

Director / Board

Other

Key Executives

Name	Title	Compensation	Gender	Year Born	Status
Russell L. Skibsted	Chief Financial Officer	USD 482,650		1959	Active
George K. Ng	Chief Executive Officer & Director	USD 473,930		1974	Active
David Young	Co-Founder, President of Research and Development & Director	USD 290,940	—	1953	Active
Patrick Lin	Co-Founder, Chief Business & Strategy Officer	USD 117,153		1965	Active
Wendy J. Guy	Co-Founder, Chief Administrative Officer & Corporate Secretary	USD 94,188		1964	Active
Steven Cha	Senior Vice President of Clinical Research	—	—	—	Active

Executive Compensation

(deduped by latest filing date per person-year)

Filing Date	Year	Name	Position	Level	Salary	Bonus	Stock Award	Option Award	Incentive	Other	Total
2026-06-18	2025	George Ng	Chief Chief Executive Officer	Founder / CEO	$400.00K	$50.00K	$50.69K	$148.69K	$0	$23.93K	$673.30K
2026-06-18	2025	Russell Skibsted	Chief Chief Financial Officer	C-Level	$400.00K	$55.00K	$21.38K	$62.73K	$0	$27.65K	$566.76K
2026-06-18	2025	Sian Bigora	Former Former Chief Chief Development and Regulatory Officer	C-Level	$367.76K	$40.00K	$19.01K	$55.76K	$0	$12.57K	$495.10K
2026-06-18	2024	George Ng	Chief Chief Executive Officer	Founder / CEO	$400.00K	$100.00K	$0	$0	$0	$21.03K	$521.03K
2026-06-18	2024	Sian Bigora	Former Former Chief Chief Development and Regulatory Officer	C-Level	$290.94K	$0	$14.48K	$0	$0	$22.83K	$328.25K
2026-06-18	2024	Russell Skibsted	Chief Chief Financial Officer	C-Level	$183.33K	$0	$49.00K	$0	$0	$11.89K	$244.23K

Total Compensation Trend

Sum of disclosed compensation by year (USD million)

Key Roles Compensation Lines

Top founder/C-level executives over time (USD million)

Supply Chain of PCSA

RELATIONS

Upstream

Elion Oncology, Inc.Aposense Ltd.TASE:APOSYuhan CorporationKRX:000100Sun Pharmaceutical Industries LimitedNSE:SUNPHARMACoNCERT Pharmaceuticals, Inc.UnconfirmedPromet Therapeutics, LLCOpus Genetics, Inc. (fka Ocuphire Pharma, Inc.)NASDAQ:IRDAkashi Therapeutics, Inc.

Downstream

Intact Therapeutics, Inc.

Proxies

Yuhan CorporationKRX:000100Sun Pharmaceutical Industries LimitedNSE:SUNPHARMAAposense Ltd.TASE:APOSOpus Genetics, Inc.NASDAQ:IRD

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer